布里奥斯丁-1 改善了动脉功能,抑制了内皮细胞自的功能
Jae Min Cho1,2,3, Seul-Ki Park4,5,6, Sohom Mookherjee4
1Department of Nutrition and Integrative Physiology, Division of Endocrinology, Metabolism and Diabetes, and Program in Molecular Medicine, University of Utah, Salt Lake City, UT, USA. jaemincho@mednet.ucla.edu.
GeroScience
|April 12, 2025
概括
用布里奥斯-1刺激蛋白激酶C (PKC) 可以恢复氧化 (NO) 的产生,并在内皮细胞自缺陷模型中改善血管功能,为与衰老相关的血管问题提供潜在的治疗策略.
科学领域:
- 内皮细胞生物学 内皮细胞生物学
- 血管生理学 血管生理学
- 自的研究研究自.
背景情况:
- 内皮细胞 (EC) 自功能受损会影响氧化 (NO) 的产生和血管功能.
- 这种损伤与缺陷的ATP产生和纯能受体信号传递有关.
- 蛋白激酶C三角酶 (PKCδ) 作为受体激活和NO生成之间的信号中间体.
研究的目的:
- 为了研究PKCδ在EC自损害条件中的功能相关性.
- 为了确定刺激PKC是否可以在自性缺陷模型中恢复内皮功能.
- 为了阐明下游的信号通道参与了这个恢复.
主要方法:
- 在EC中利用了与自相关的基因3 (Atg3) 的淘汰.
- 向EC和小鼠模型注射PKC激动剂布里奥斯塔丁-1.
- 评估了内皮氧化合成酶 (eNOS) 的剪切压力诱导的酸化.
- 在小鼠模型的股骨动脉和大脑动脉中测量了血管扩张.
- 研究了下游PKC/PKD信号通路的作用.
主要成果:
- 布里奥斯塔丁-1恢复了Atg3敲击EC中的剪切压力诱导的eNOS酸化.
- 布里奥斯塔丁-1逆转了来自遗传和老年EC自性损害小鼠的动脉压缩血管扩张.
- NO合成酶抑制阻止了布里奥斯丁-1.1的血管扩张作用.
- 下游PKC/PKD标 (p-PKDS744/S748和p-PKDS916) 的抑制减轻了布里奥斯塔丁-1对血管扩张的正常化作用.
结论:
- 通过PKC/PKD刺激,可以在患有抑制EC自的病态中,如衰老,战略性地恢复受损的内皮功能.
- 准PKC/PKD途径为与年龄相关的血管功能障碍提供了潜在的治疗方法.
- 这项研究强调了自在维持内皮氧化生产和血管健康方面的关键作用.
相关概念视频
Autophagy
4.0K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.0K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Autophagic Cell Death
2.7K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.7K
Delivery Pathways to the Lysosome
6.1K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K


